Reuters logo
BRIEF-BioCryst Pharmaceuticals Q4 loss per share $0.06
February 27, 2017 / 11:52 AM / in 9 months

BRIEF-BioCryst Pharmaceuticals Q4 loss per share $0.06

Feb 27 (Reuters) - Biocryst Pharmaceuticals Inc

* Biocryst reports fourth quarter and full year 2016 financial results

* Q4 loss per share $0.06

* Q4 revenue $9.0 million versus $4.6 million

* Q4 revenue view $4.1 million -- Thomson Reuters I/B/E/S

* Q4 earnings per share view $-0.23 -- Thomson Reuters I/B/E/S

* BioCryst Pharmaceuticals Inc - sees its 2017 operating expenses to be in range of $53 to $73 million

* BioCryst Pharmaceuticals Inc - for three months ended december 31, 2016, total revenues increased to $9.0 million from $4.6 million in Q4 of 2015

* BioCryst Pharmaceuticals Inc - expects its 2017 net operating cash use to be in range of $30 to $50 million Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below